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2. Post procedure not visualizing in IVUS as well as in ANGIO. The
aneurysm could not be explained.
The strategy which we followed and did it in our place Right or
Wrong...?PHYSIOLOGIC LESION ASSESSMENT (TCTAP C-206)
TCTAP C-206
Bystander Coronary Artery Lesion in Non-ischemic
Cardiomyopathy: Should We Treat It?
Asri Bin Said,1 Nor Hanim Mohd Amin,2 Khaw Chee Sin,2
Tiong Kiam Ong2
1Universiti Malaysia Sarawak, Malaysia; 2Sarawak Heart Centre,
MalaysiaCLINICAL INFORMATION
Patient Initials or Identifier Number. PE
Relevant Clinical History and Physical Exam. A 71-year-old lady, with a
background history of diabetes mellitus, hypertension and atrial
fibrillation, presented with progressive heart failure symptoms for the
past 1 month with occasional chest pain. She was previously under
medical clinic follow up and the last echocardiogram 4 months prior
was normal with an EF >55%. The working diagnosis was that she may
have had a silent myocardial infarction. She was started on Tab Fru-
semide, Tab Spironolactone, Tab Aspirin, and Tab Bisoprolol.
Relevant Test Results Prior to Catheterization. A repeat echocardiogram
showed an EF 25% with global hypokinesia. A cardiac MRI was ar-
ranged to assess for myocardial viability. Interestingly the MRI
showed no areas of infarction but there was a mid-wall fibrosis at the
posterior LV and at the insertion point of the RV.
Relevant Catheterization Findings. As she had had chest pain, a diag-
nostic angiogram was also done which showed an intermediate lesion
in the LAD 50% stenosis and a diseased RCA with 90% proximal and a
long diffuse disease from mid to distal of about 80-90%.
INTERVENTIONAL MANAGEMENT
Procedural Step. We decided to do further assessment of the LAD
lesion.
A 6Fr EBU 3.5 guiding catheter was used to engage the left coronary
artery. The LAD was wired distally with a St Jude FFR floppy wire.
Resting FFR was 0.89. IC Adenosine 120 mcg bolus was given however
the post adenosine FFR was still not significant at 0.86. Therefore, the
lesion was left for medical therapy.
As she had had history of chest pain, we decided to intervene for the
RCA lesion. We proceeded to engage the right coronary artery with a
6F JR4 guiding catheter. A BMW coronary wire was passed down to
the distal RCA. Pre-dilatation was done sequentially to the proximal,
mid, and distal lesion with a semi-compliant balloon 2.0 x 12 mm up to
14 ATM. The mid to distal lesion was treated with drug coated balloon
Sequent Please 2.25 x 40 mm at 8 ATM for 60seconds. The proximal
lesion was treated with a bare metal stent Azule 2.5 x 15 mm and
inflated at 10 ATM for 30 seconds. The stent was then post dilated
with a non-compliant Saphire II balloon 3.0 x 10 mm at 16 ATM for 20
seconds. The final angiogram showed a well expanded stent in the
proximal segment and minimal recoil in the distal segment treated
with drug coated balloon. There was TIMI 3 flow to the distal RCA.
Post procedure was uneventful.
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ischemic cardiomyopathy. Functional assessment is required, espe-
cially in cases where the patient also had had angina. On follow up,
the patient did very well and was out of heart failure. Her repeated
echocardiogram showed remarkable improvement with EF >55%, and
she no longer had chest pain.
This case illustrated that selective PCI and optimal medical therapy
can improve the outcome of non-ischemic cardiomyopathy.View publication statsINNOVATIVE DEVICES AND FUTURISTIC THERAPIES
(TCTAP C-207)
TCTAP C-207
Atrial Septum Fenestration for Patient with Idiopathic
Pulmonary Artery Hypertension
Tagir Aminov,1 Irina E. Nikolaeva,2 Vladimir V. Plechev,2
Igor V. Buzaev,2 Bogdan Aleksandrovich Oleynik,3
Eustaquio M. Onorato,4 Ilgiz Zagitov,2 Gulchachak Khalikova2
1Republican Cardiologic Center, Russian Federation;
2Republican Centre of Cardiovascular Diseases, Bashkir State
Medical University, Russian Federation; 3GBUZ Republic Heart
Centre, Russian Federation; 4Humanitas Gavazzeni Clinic,
Bergamo, ItalyCLINICAL INFORMATION
Patient Initials or Identifier Number. A.B.
Relevant Clinical History and Physical Exam. A 21 y.o. M admitted to
Cardiac Center with low tolerance to physical exercise, exertional
dyspnea.
Anamnesmorbi: exertional dyspnea x 10 y. First presyncope in
06.2014. Cardiac catheterization in 10.2014 - Pulmonary
Hypertension.
Meds: bosentan 250mg/day, diltiazem 180mg/day, iloprost 10 mg x
6/day, furosemide 80mg, eplerenone 50mg, hydrocortisone 10-10-
5mg, levothyroxine75mkg.
SH: 2011 endosupracellarcranyopharingioma resection. Secondary
hypothyroidism, hypogonadism, hypocorticism.
Relevant Test Results Prior to Catheterization. EchoCG before admission
(24.01.17.)
Left ventricle – 3.9 cm, Left atrium - 3.7 cm, Right ventricle - 4.7 cm,
wall – 0.7 cm, Right atrium – 8.5 x 6.4 cm, EF(Lv) – 70%, EF(Rv) – 40%
Sim, S(Ra) – 59 cm2.
Dilatation of the right chambers with signs of RV overload and a
moderate decrease in its contractile function. Doppler: mitral regur-
gitation (þ), tricuspid regurgitation (þþþ) with gradient 60 mmHg.
Right ventricle pressure systolic 80 mmHg, diastolic 40 mmHg
Relevant Catheterization Findings. Atrioseptostomia with implantation
of the “modified” occluder MemoPart under the control of the Ultra
ICE probe and TTE. A conventional ASD occluder (Memopart, LePu
Medical etc, 14 mm) was modified by keeping out all the polyester
patches (left disc, right disc, and waist) and fenestrated by balloon
dilation before implantation.
INTERVENTIONAL MANAGEMENT
Procedural Step. Atrioseptostomia with implantation of the “modi-
fied” occlude Memo Part under the control of the Ultra ICE probe and
TTE. Trans septal puncture of the atrial septum was performed under
TTE and Ultra ICE control in the cath lab. Consecutively, pre-dilata-
tion of atrial puncture site by balloons EMPIRA 1.5x20, EMPIRA
NC3.75x15 and TYSHAK 12 mm and 15 mm advanced over the guide
wire in the left atrium were performed. A conventional ASD occluder
(Memopart, LePu Medical etc, 14 mm) was modified by keeping out all
the polyester patches (left disc, right disc, and waist) and fenestrated
by balloon dilation before implantation. The Nitinol wires at the
border of this fenestration were keep opened by stitches with a final
7 mm hole. So, the home-made “fenestrated” occluder was finally
implanted under the control of the Ultra ICE probe and TTE. Control of
the stability of the occluder’s position by “push & pull test” on fluo-
roscopy, intracardiac examination, and TTE was accomplished and we
finally deployed the modified occluder appropriately.
Postoperative period with no complications.
